NEW THERAPEUTIC USE OF CHONDROITIN SULPHATE (Machine-translation by Google Translate, not legally binding)
The present invention relates to the use of an alkaline or alkaline earth metal chondroitin sulphate, which comes from an enzymatic hydrolysis of animal cartilage, for the preparation of a medicament for the treatment or prevention of psoriasis with skin affection in a mammal. Preferably the sodium...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention relates to the use of an alkaline or alkaline earth metal chondroitin sulphate, which comes from an enzymatic hydrolysis of animal cartilage, for the preparation of a medicament for the treatment or prevention of psoriasis with skin affection in a mammal. Preferably the sodium chondroitin sulphate has an average molecular weight between 10,000 and 20,000 daltons, and is administered orally. (Machine-translation by Google Translate, not legally binding)
Nuevo uso terapéutico de condroitín sulfato. La presente invención se refiere al uso de condroitín sulfato de metal alcalino o alcalinotérreo, que proviene de una hidrólisis enzimática de cartílago animal, para el tratamiento de la psoriasis con afectación dérmica en un mamífero. Preferentemente el condroitín sulfato de sodio tiene un peso molecular medio comprendido entre 10.000 y 20.000 daltons, y se administra por vía oral. |
|---|